Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

Article  Google Scholar 

Schito L, Semenza GL (2016) Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer 2:758–770

Article  PubMed  Google Scholar 

Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y (2019) Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer 18:157

Article  PubMed Central  Google Scholar 

Wigerup C, Påhlman S, Bexell D (2016) Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther 164:152–169

Article  CAS  PubMed  Google Scholar 

Luo F, Lu FT, Cao JX, Ma WJ, Xia ZF, Zhan JH, Zeng KM, Huang Y, Zhao HY, Zhang L (2022) HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer. Cancer Lett 531:39–56

Article  CAS  PubMed  Google Scholar 

Musial C, Zaucha R, Kuban-Jankowska A, Konieczna L, Belka M, Marino Gammazza A, Baczek T, Cappello F, Wozniak M, Gorska-Ponikowska M (2021) Plausible role of estrogens in pathogenesis, progression and therapy of lung cancer. Int J Environ Res Public Health 18:648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, Nichols M (2005) Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 65:1598–1605

Article  CAS  PubMed  Google Scholar 

Deli T, Orosz M, Jakab A (2020) Hormone replacement therapy in cancer survivors- review of the literature. Pathol Oncol Res 26:63–78

Article  CAS  PubMed  Google Scholar 

Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM (2005) Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 65:1459–1470

Article  CAS  PubMed  Google Scholar 

Gao X, Cai Y, Wang Z, He W, Cao S, Xu R, Chen H (2019) Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective. J Transl Med 17:308

Article  PubMed  PubMed Central  Google Scholar 

Liu S, Hu C, Li M, An J, Zhou W, Guo J, Xiao Y (2022) Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression. Cell Death Dis 13:70

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu W, Ding J, He M, Chen Y, Wang R, Han Z, Xing EZ, Zhang C, Yeh S (2019) Estrogen receptor β promotes the vasculogenic mimicry and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer. Oncogene 38:225–1238

Article  Google Scholar 

Ullah A, Leong SW, Wang J, Wu Q, Ghauri MA, Sarwar A, Su Q, Zhang Y (2021) Cephalomannine inhibits hypoxia-induced cellular function via the suppression of APEX1/HIF-1α interaction in lung cancer. Cell Death Dis 12:490

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su Q, Wu Q, Chen K, Wang J, Sarwar A, Zhang Y (2022) Induction of estrogen receptor β-mediated autophagy sensitizes breast cancer cells to TAD1822-7, a novel biphenyl urea taspine derivative. Mol Biol Rep 49:1223–1232

Article  CAS  PubMed  Google Scholar 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su Q, Wang J, Wu Q, Ullah A, Ghauri MA, Sarwar A, Chen L, Liu F, Zhang Y (2021) Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer. Phytomedicine 84:153503

Article  CAS  PubMed  Google Scholar 

Su Q, Wang J, Liu F, Zhang Y (2021) Blocking Parkin/PINK1-mediated mitophagy sensitizes hepatocellular carcinoma cells to sanguinarine-induced mitochondrial apoptosis. Toxicol In Vitro 66:104840

Article  Google Scholar 

Lin L, Li X, Li Y, Lang Z, Li Y, Zheng J (2023) Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis. J Pharm Anal. https://doi.org/10.1016/j.jpha.2023.11.009

Article  PubMed  PubMed Central  Google Scholar 

Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA (2001) Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230–4251

Article  CAS  PubMed  Google Scholar 

Bross PF, Cohen MH, Williams GA, Pazdur R (2002) FDA drug approval summaries: fulvestrant. Oncologist 7:477–480

Article  CAS  PubMed  Google Scholar 

Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, Lucas J, Boddie P, Khan A, Manosalva Pérez N, Fornes O, Leung TY, Aguirre A, Hammal F, Schmelter D, Baranasic D, Ballester B, Sandelin A, Lenhard B, Vandepoele K, Wasserman WW, Parcy F, Mathelier A (2022) JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res 50:165–173

Article  Google Scholar 

Xiao H, Zhao R, Meng W, Liao Y (2023) Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer. J Pharm Anal 13:625–639

Article  PubMed  PubMed Central  Google Scholar 

Rashid M, Zadeh LR, Baradaran B, Molavi O, Ghesmati Z, Sabzichi M, Ramezani F (2021) Up-down regulation of HIF-1α in cancer progression. Gene 798:145796

Article  CAS  PubMed  Google Scholar 

Bosco MC, D’Orazi G, Del Bufalo D (2020) Targeting hypoxia in tumor: a new promising therapeutic strategy. J Exp Clin Cancer Res 39:8

Article  PubMed  PubMed Central  Google Scholar 

Xu H, Chen Y, Li Z, Zhang H, Liu J, Han J (2022) The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo. Eur J Pharmacol 930:175154

Article  CAS  PubMed  Google Scholar 

Zhang X, Kumstel S, Jiang K, Meng S, Gong P, Vollmar B, Zechner D (2019) LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer. J Adv Res 20:9–21

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sato M, Hirose K, Kashiwakura I, Aoki M, Kawaguchi H, Hatayama Y, Akimoto H, Narita Y, Takai Y (2015) LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells. Mol Med Rep 12:3462–3468

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mai L, Luo M, Wu JJ, Yang JH, Hong LY (2019) The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells. Neoplasma 66:776–784

Article  CAS  PubMed  Google Scholar 

Naik R, Han S, Lee K (2015) Chemical biology approach for the development of hypoxia inducible factor (HIF) inhibitor LW6 as a potential anticancer agent. Arch Pharmacal Res 38:1563–1574

Article  CAS  Google Scholar